Skip to main content
Navigate Up
Sign In
 

How studying those with Down syndrome gets us answers about Alzheimer's


​KUSA - 9NEWS has been reporting extensively about a drug called Leukine that may prove to be the first treatment capable of reversing many of the effects of Alzheimer's. That's important because presently, Alzheimer's remains the only major disease in our country without a prevention, treatment or cure. 
 
Someone new is diagnosed with the disease in the U.S every 66 seconds. In 2017, Alzheimer's and other types of dementia will cost the nation $259 billion. 
 
Researchers are racing to find a solution, and many believe one key may be hidden in the biology of the Down syndrome population. There are doctors at CU Anschutz for example, who refer to people with Down syndrome as "a medical gift to society." That's because their unique biology makes them a blueprint for medical research in areas that include heart disease, immune systems disorders, soft tissues cancers and perhaps most importantly at this moment in time, Alzheimer's disease.